It was mandated by the food and drug administration fda. Cellcept 200 mgml powder for oral suspension each bottle contains 35 g. Ceprotin protein c concentrate human full prescribing information 1. Cellcept can be taken either orally or through intravenous solution. Inspect the resulting slightly yellow solution for particulate matter and discoloration prior to further dilution. Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Mycophenolate mofetil tablets are used to prevent your body rejecting a transplanted kidney, heart or liver.
Retreatment of pagets disease after a single treatment with reclast in pagets disease an extended remission period is observed. Labelingcontainercarton labels, labeling package insert. Nevertheless, gatcf will consider providing cellcept for your patient with this admonition, based upon your medical order, within. The infusion time must not be less than 15 minutes given over a constant infusion rate. Highlights of prescribing information these highlights do not include all the information needed to use dupixent safely and effectively. Aih can affect any ethnicity, and it appears to occur in women more frequently than in men. Gamunexc immune globulin injection official site for. The mycophenolate rems is a program to tell doctors, nurses, pharmacists and patients about the risks of taking mycophenolate during pregnancy. The chemical name for mycophenolate mofetil mmf is 2morpholinoethyl e6 1,3dihydro4hydroxy6. Myfortic is to be used in combination with cyclosporine and corticosteroids. These highlights do not include all the information needed to use cellcept. Cellcept mycophenolate mofetil is indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressants. It is an immunosuppressant, a type of medicine that reduces the bodys ability to reject a transplanted organ. Myfortic tablets should not be crushed, chewed, or cut prior to ingesting.
Cellcept is available for oral administration as capsules containing 250 mg of mycophenolate mofetil, tablets containing 500 mg of mycophenolate mofetil, and as a powder for oral suspension, which when constituted contains 200 mgml mycophenolate. Reconstitution after calculating the number of vials needed, using aseptic technique, reconstitute each vial of thymoglobulin with 5 ml of sterile water for injection, usp swfi. Cellcept mycophenolate mofetil mmf is indicated for the prophylaxis of organ rejection,in recipients of allogeneic kidneysee clinical studies 14. The medication usually is started at a dose of 500 mg twice per day. As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in basel, switzerland. Highlights of prescribing information an initial dose. Cellcept is available for oral administration as capsules containing 250 mg of mycophenolate mofetil, tablets containing 500 mg of mycophenolate mofetil, and as a powder for oral suspension, which when constituted contains 200 mgml mycophenolate mofetil. Cellcept may not be appropriate for some people, including those with a history of diabetes or cancer. Cellcept intravenous must not be administered as a bolus. Therapeutic drug monitoring of mpa may be appropriate when switching combination therapy e. The parent drug, mycophenolate mofetil, can be measured systemically during. More recently, cellcept has been used to treat other immunemediated diseases, such as multiple sclerosis. The binding of nifedipine to voltagedependent and possibly receptoroperated channels in vascular smooth muscle results in an inhibition of calcium influx through these channels.
See full prescribing information for complete boxed. Mycophenolate mofetil tablets is used together with. Patients receiving the drug should be managed in facilities. See important safety including boxed warnings for more information.
In some patients, it is necessary to convert from mmf cellcept to ecmps myfortic to improve gi tolerability. Today, roche creates innovative medicines and diagnostic tests that help millions of patients globally. If a lack of vacuum in the vial is noted while adding. Following reconstitution, cellcept intravenous must be administered by slow intravenous infusion over a period of no less than 2 hours by either peripheral or central vein, as rapid infusion increases the risk of local adverse reactions such as phlebitis and thrombosis see adverse. The chemical name for mycophenolate mofetil mmf is 2morpholinoethyl e6 1,3. The tablets should be swallowed whole in order to maintain the integrity of the enteric coating. Gamunexc immune globulin injection human, 10% caprylatechromatography purified is indicated for the treatment of primary humoral immunodeficiency disease pidd in patients 2 years of age and older, idiopathic thrombocytopenic purpura itp in adults and children, and chronic inflammatory demyelinating polyneuropathy cidp in adults. The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned. Patient information cellcept mycophenolate mofetil. Cellcept should be used concomitantly with cyclosporine and corticosteroids. Use of nulojix for prophylaxis of organ rejection in transplanted organs other than kidney has. Before inserting the tip of the dispenser into bottle adapter, push the. Prograf capsules and prograf granules are not interchangeable or substitutable for other tacrolimus extendedrelease products. Highlights of prescribing information hypocalcemia.
A healthcare provider may prescribe cellcept following a kidney, heart, or liver transplant to help prevent the body from attacking and rejecting the new organ. Interrupt and then reduce or discontinue stivarga for hepatotoxicity as manifested by elevated liver. Before inserting the tip of the dispenser into bottle. Envarsus xr is proven to help prevent organ rejection in people who have had a kidney transplant. Cellcept oral dosage forms capsules, tablets or oral suspension should not be used interchangeably with mycophenolic acid delayedrelease tablets without supervision of a physician with experience in immunosuppressive therapy because the rates of absorption following the administration of cellcept oral dosage. Treatment of anemia due to chronic kidney disease ckd in patients on dialysis and not on dialysis. Cellcept 500 mg filmcoated tablets contain the following nonmedicinal. Cellcept, myfortic mycophenolate dosing, indications. The inactive ingredients are polysorbate 62 80, 25 mg, and citric acid, 5 mg. Hepatotoxicity severe and sometimes fatal hepatotoxicity has occurred in clinical trials see warnings and precautions 5. Adults the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Insert the oral syringe adapter plastic tube with stopper tightly into the bottle until it is even with the top of the bottle figure 2. Inactive ingredients in cellcept 250 mg capsules include croscarmellose sodium.
In clinical trials, one class iii patients death was judged attributable to the interruption of flolan. See full prescribing information for complete boxed warning. Cellcept is supplied as 250 mg capsules and 500 mg tablets. Jakafi is indicated for treatment of intermediate or highrisk myelofibrosis mf, including primary mf, postpolycythemia vera mf and postessential thrombocythemia mf in adults. Dailymed cellcept mycophenolate mofetil tablet, film. The fact that the use for which you are prescribing cellcept is not listed in the fdaapproved label indicates that the fda has not approved the efficacy, dosage amount or safety of cellcept when used for such a use. Uloric should only be used in patients who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable see indications and usage 1. Each pharmacy bulk package bottle contains ampicillin sodium equivalent to 10 grams of ampicillin. Do not remove the oral syringe adapter from the bottle once inserted.
This is because rate of absorption following the administration of an extendedrelease tacrolimus product is not equivalent to that of an immediaterelease tacrolimus drug product. Flolan is a potent pulmonary and systemic vasodilator and can cause hypotension and other. This prescription medicine works by blocking certain enzymes in the body, making the immune system less active. The solution after constitution is clear and colorless. Reconstitute three 3 vials of cellcept intravenous by injecting 14 ml of 5% dextrose injection usp into each vial. Monitor hepatic function prior to and during treatment see warnings and precautions 5. Each vial of cellcept intravenous contains the equivalent of 500 mg 61 mycophenolate mofetil as the hydrochloride salt. Transplant clinical pearls for the nontransplant pharmacist. Ampicillin for injection, usp is white to offwhite crystalline powder. If you have any further questions, ask your doctor, pharmacist or nurse. This leaflet is part iii of a threepart product monograph published when.
Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for cellcept mycophenolate. Cellcept, innmycophenolate mofetil european medicines agency. Cellcept mycophenolate mofetil capsules mycophenolate. Cellcept mycophenolate mofetil for oral suspension. Nifedipine is a peripheral arterial vasodilator which acts directly on vascular smooth muscle. Autoimmune hepatitis aih is a chronic disease of unknown cause with persistent inflammation of the liver and the potential for necrosis and progression to cirrhosis associated with it. This emedtv article describes several warnings and safety precautions for cellcept, with details on potentially serious complications that may occur. Sodium hydroxide may have been used in the 63 manufacture of cellcept intravenous to adjust the ph. Use nulojix only in patients who are epsteinbarr virus ebv seropositive. Highlights of prescribing information these highlights do. Cellcept mycophenolate mofetil is an immunosuppressive medication used to lower the bodys natural immunity in patients who receive organ transplants. Uloric is a xanthine oxidase xo inhibitor indicated for the chronic management of.
73 1245 1213 1009 71 411 765 1429 1361 151 1256 1450 870 12 1364 1426 722 577 162 79 820 1026 1002 1051 1109 1097 215 306 191 1204 1056 1191 971 1075 428 107 902 979 453 91 1378 741